FSRH CEU Statement: Drospirenone Progestogen-only Pill (DRSP POP) (Jan 24)

66c84d7597844766dd3a1d96520b6066

Published on: 10 January 2024

File size: 437kb PDF

File type: Clinical Statements

This CEU statement provides a brief summary of key information on a new drospirenone progestogen-only pill (DRSP POP) Slynd® available now in the UK.

Your download should start automatically. If not download directly.